Skip to main content
All lobbying firms

LMH STRATEGIC SOLUTIONS

Registrant on federal lobbying filings · filed 2025 to 2026

$5,960,000 Income reported
31 Clients represented
155 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. 8 filings on this record were restated by a later amendment and are left out of every total here. Everything on this page is grouped by the registrant's LDA id (401108183), not by name.

 Clients 31
 Lobbyists named 3
  • ALANNA TEMME 160 filings · through 2026 Legislative Director, U.S. Representative Jon Porter
  • SOPHIE KHANAHMADI 46 filings · through 2026 Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions
  • AMY CHEVALIER EFANTIS 4 filings · through 2026 Legislative Director, Rep. Artur Davis; Legislative Assistant, Rep. Tom Barrett

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $3,440,000 71 filings
  • 2025 $2,520,000 84 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • HOUSE OF REPRESENTATIVES 123
  • SENATE 122
  • Health & Human Services, Dept of (HHS) 62
  • Executive Office of the President (EOP) 60
  • Office of Management & Budget (OMB) 1
 Recent filings 163 total
Q3 report
PUBLIC STRATEGIES WASHINGTON OBO AMERICAN ASSOCIATION OF NURSE ANESTHESIOLOGY
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 19, 2026
View →
Registration
PUBLIC STRATEGIES WASHINGTON OBO AMERICAN ASSOCIATION OF NURSE ANESTHESIOLOGY
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 19, 2026
View →
Q3 report
UNIVERSITY OF LOUISVILLE HEALTH
3rd Quarter 2026 (July 1 - Sep 30) · $60,000 income · posted Oct 19, 2026
View →
Q3 report
STEALTH BIOTHERAPEUTICS INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View →
Q3 report
SAVARA INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View →
Q3 report
REZOLUTE, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View →
Q3 report
REGENXBIO INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 19, 2026
View →
Q3 report
PTC THERAPEUTICS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 19, 2026
View →
Q3 report
NEUROPACE, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 19, 2026
View →
Q3 report
NATERA, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
MIRUM PHARMACEUTICALS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 19, 2026
View →
Q3 report
MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $120,000 income · posted Oct 19, 2026
View →
Q3 report
MEDICAL DEVICE MANUFACTURERS ASSOCIATION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $20,000 income · posted Oct 19, 2026
View →
Q3 report
IONIS PHARMACEUTICALS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 19, 2026
View →
Q3 report
INSMED INCORPORATED
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q2 termination
INCYTE CORPORATION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
HARMONY BIOSCIENCES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
GLAXOSMITHKLINE LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
ERISA INDUSTRY COMMITTEE (ERIC)
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 19, 2026
View →

Showing the 20 most recent of 163 filings. Search the explorer for "LMH STRATEGIC SOLUTIONS".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem